Correlation Between Cardio Diagnostics and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and TC BioPharm plc, you can compare the effects of market volatilities on Cardio Diagnostics and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and TC BioPharm.

Diversification Opportunities for Cardio Diagnostics and TC BioPharm

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cardio and TCBPW is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and TC BioPharm go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and TC BioPharm

Given the investment horizon of 90 days Cardio Diagnostics is expected to generate 1.32 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Cardio Diagnostics Holdings is 2.25 times less risky than TC BioPharm. It trades about 0.12 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2.32  in TC BioPharm plc on September 5, 2024 and sell it today you would lose (0.81) from holding TC BioPharm plc or give up 34.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  TC BioPharm plc

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics displayed solid returns over the last few months and may actually be approaching a breakup point.
TC BioPharm plc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Cardio Diagnostics and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and TC BioPharm

The main advantage of trading using opposite Cardio Diagnostics and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Cardio Diagnostics Holdings and TC BioPharm plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites